Intravitreal aflibercept for the treatment of patients with neovascular age-related macular degeneration in routine clinical practice in Latin America: the AQUILA study

被引:0
|
作者
Lihteh Wu
Arnaldo F. Bordon
Martin Charles
Francisco J. Rodríguez
JinKyung Lee
Tobias Machewitz
Margarete Mueller
Gabriela del Carmen Gay
Jans Fromow-Guerra
机构
[1] Asociados de Macula,Fundación Oftalmológíca
[2] Vitreo y Retina de Costa Rica,undefined
[3] Primer Piso Torre Mercedes,undefined
[4] Hospital Oftalmológico de Sorocaba,undefined
[5] R. Nabek Shiroma,undefined
[6] Centro Oftalmológico Dr Charles,undefined
[7] Universidad del Rosario School of Medicine,undefined
[8] Bayer AG,undefined
[9] Bayer SA,undefined
[10] Macula Retina Consultores,undefined
关键词
Macula; Neovascularization; Vision; Clinical trial;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Intravitreal aflibercept for the treatment of patients with neovascular age-related macular degeneration in routine clinical practice in Latin America: the AQUILA study
    Wu, Lihteh
    Bordon, Arnaldo F.
    Charles, Martin
    Rodriguez, Francisco J.
    Lee, JinKyung
    Machewitz, Tobias
    Mueller, Margarete
    Gay, Gabriela Del Carmen
    Fromow-Guerra, Jans
    [J]. INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2022, 8 (01)
  • [2] Intravitreal aflibercept for the treatment of patients with diabetic macular edema in routine clinical practice in Latin America: the AQUILA study
    Francisco J. Rodríguez
    Lihteh Wu
    Arnaldo F. Bordon
    Martin Charles
    JinKyung Lee
    Tobias Machewitz
    Margarete Mueller
    Gabriela del Carmen Gay
    Jans Fromow-Guerra
    [J]. International Journal of Retina and Vitreous, 8
  • [3] Intravitreal aflibercept for the treatment of patients with diabetic macular edema in routine clinical practice in Latin America: the AQUILA study
    Rodriguez, Francisco J.
    Wu, Lihteh
    Bordon, Arnaldo F.
    Charles, Martin
    Lee, JinKyung
    Machewitz, Tobias
    Mueller, Margarete
    Gay, Gabriela del Carmen
    Fromow-Guerra, Jans
    [J]. INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2022, 8 (01)
  • [4] Intravitreal Aflibercept Treatment Strategies in Routine Clinical Practice of Neovascular Age-Related Macular Degeneration in Belgium: A Retrospective Observational Study
    Joke Ruys
    Els Mangelschots
    Julie Jacob
    Filip Mergaerts
    Alexandra Kozyreff
    Werner Dirven
    [J]. Ophthalmology and Therapy, 2020, 9 : 993 - 1002
  • [5] Intravitreal Aflibercept Treatment Strategies in Routine Clinical Practice of Neovascular Age-Related Macular Degeneration in Belgium: A Retrospective Observational Study
    Ruys, Joke
    Mangelschots, Els
    Jacob, Julie
    Mergaerts, Filip
    Kozyreff, Alexandra
    Dirven, Werner
    [J]. OPHTHALMOLOGY AND THERAPY, 2020, 9 (04) : 993 - 1002
  • [6] Intravitreal aflibercept for neovascular age-related macular degeneration
    Xu, David
    Kaiser, Peter K.
    [J]. IMMUNOTHERAPY, 2013, 5 (02) : 121 - 130
  • [7] Aflibercept for Intravitreal Injection In Neovascular Age-Related Macular Degeneration
    Frampton, James E.
    [J]. DRUGS & AGING, 2012, 29 (10) : 839 - 846
  • [8] Aflibercept for Intravitreal InjectionIn Neovascular Age-Related Macular Degeneration
    James E. Frampton
    [J]. Drugs & Aging, 2012, 29 : 839 - 846
  • [9] Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration
    Chang, Andrew A.
    Li, Haitao
    Broadhead, Geoffrey K.
    Hong, Thomas
    Schlub, Timothy E.
    Wijeyakumar, Wijeyanthy
    Zhu, Meidong
    [J]. OPHTHALMOLOGY, 2014, 121 (01) : 188 - 192
  • [10] Intravitreal aflibercept: its role in treatment of neovascular age-related macular degeneration
    Cundy, Olivia
    Shah, Mital
    Downes, Susan M.
    [J]. EXPERT REVIEW OF OPHTHALMOLOGY, 2018, 13 (02) : 75 - 86